Ranbaxy gets nod to sell anti-schizophrenia drug - Economic Times

Read More

Ranbaxy gets nod to sell anti-schizophrenia drug Economic Times, India "The company has received an approval from the Therapeutic Goods Administration (TGA), Department of Health & Ageing of the Australian government, for the registration of Ozidal Risperidone 0.5, 1, 2, 3 and 4 mg tablets in Australia. ... Ranbaxy gets Australia nod for antipsychotic drug Livemint Ranbaxy receives approval for OZIDAL Risperidone Tablets from TGA ... Equity Bulls Ranbaxy: gets Australia nod for antipsychotic drug Reuters all 7 news articles